304 related articles for article (PubMed ID: 32340025)
1. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
Takenaga K; Akimoto M; Koshikawa N; Nagase H
PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025
[TBL] [Abstract][Full Text] [Related]
2. ST2 Signaling in the Tumor Microenvironment.
Chang CP; Hu MH; Hsiao YP; Wang YC
Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
[TBL] [Abstract][Full Text] [Related]
3. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
4. An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.
O'Donnell C; Mahmoud A; Keane J; Murphy C; White D; Carey S; O'Riordain M; Bennett MW; Brint E; Houston A
Br J Cancer; 2016 Jan; 114(1):37-43. PubMed ID: 26679377
[TBL] [Abstract][Full Text] [Related]
5. Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment.
Akimoto M; Maruyama R; Takamaru H; Ochiya T; Takenaga K
Nat Commun; 2016 Nov; 7():13589. PubMed ID: 27882929
[TBL] [Abstract][Full Text] [Related]
6. Role of the IL-33/ST2L axis in colorectal cancer progression.
Akimoto M; Takenaga K
Cell Immunol; 2019 Sep; 343():103740. PubMed ID: 29329638
[TBL] [Abstract][Full Text] [Related]
7. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
8. Dynamic observation of IL-33 and its receptors in HIV patients who received HAART.
He B; Zheng L; Zhou H; He Y; Chen Z; Xiao S; Wang H; Ling Y; Zheng Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):73-77. PubMed ID: 28466817
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Production of Soluble ST2 in Heart Failure.
Pascual-Figal DA; Pérez-Martínez MT; Asensio-Lopez MC; Sanchez-Más J; García-García ME; Martinez CM; Lencina M; Jara R; Januzzi JL; Lax A
Circ Heart Fail; 2018 Dec; 11(12):e005488. PubMed ID: 30562096
[TBL] [Abstract][Full Text] [Related]
10. DHT and Insulin Upregulate Secretion of the Soluble Decoy Receptor of IL-33 From Decidualized Endometrial Stromal Cells.
Salamon D; Ujvari D; Hellberg A; Hirschberg AL
Endocrinology; 2023 Nov; 165(1):. PubMed ID: 37972259
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism.
Sun X; He X; Zhang Y; Hosaka K; Andersson P; Wu J; Wu J; Jing X; Du Q; Hui X; Ding B; Guo Z; Hong A; Liu X; Wang Y; Ji Q; Beyaert R; Yang Y; Li Q; Cao Y
Gut; 2022 Jan; 71(1):129-147. PubMed ID: 33568427
[TBL] [Abstract][Full Text] [Related]
12. IL-33/ST2 axis affects the polarization and efferocytosis of decidual macrophages in early pregnancy.
Sheng YR; Hu WT; Wei CY; Tang LL; Liu YK; Liu YY; Qiu JP; Li DJ; Zhu XY
Am J Reprod Immunol; 2018 Jun; 79(6):e12836. PubMed ID: 29500844
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia induces downregulation of the tumor-suppressive sST2 in colorectal cancer cells via the HIF-nuclear IL-33-GATA3 pathway.
Akimoto M; Susa T; Okudaira N; Koshikawa N; Hisaki H; Iizuka M; Okinaga H; Takenaga K; Okazaki T; Tamamori-Adachi M
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2218033120. PubMed ID: 37094129
[TBL] [Abstract][Full Text] [Related]
14. Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.
Bandara G; Beaven MA; Olivera A; Gilfillan AM; Metcalfe DD
Eur J Immunol; 2015 Nov; 45(11):3034-44. PubMed ID: 26256265
[TBL] [Abstract][Full Text] [Related]
15. IL-13 Controls IL-33 Activity through Modulation of ST2.
Zhang M; Duffen JL; Nocka KH; Kasaian MT
J Immunol; 2021 Dec; 207(12):3070-3080. PubMed ID: 34789557
[TBL] [Abstract][Full Text] [Related]
16. IL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic Asthmatics.
Mitchell PD; Salter BM; Oliveria JP; El-Gammal A; Tworek D; Smith SG; Sehmi R; Gauvreau GM; O Apos Byrne PM
Int Arch Allergy Immunol; 2018; 176(2):133-142. PubMed ID: 29694974
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model.
Yin X; Cao H; Wei Y; Li HH
Hypertens Res; 2019 Nov; 42(11):1664-1671. PubMed ID: 31235844
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells.
Schmieder A; Multhoff G; Radons J
Cytokine; 2012 Nov; 60(2):514-21. PubMed ID: 22819319
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice.
Oshio T; Komine M; Tsuda H; Tominaga SI; Saito H; Nakae S; Ohtsuki M
J Dermatol Sci; 2017 Feb; 85(2):106-114. PubMed ID: 27839630
[TBL] [Abstract][Full Text] [Related]
20. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma.
Lee HY; Rhee CK; Kang JY; Byun JH; Choi JY; Kim SJ; Kim YK; Kwon SS; Lee SY
Exp Lung Res; 2014 Mar; 40(2):66-76. PubMed ID: 24446582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
